RxDoctor Payments Data

Hamid Ghanbari, MD

Clinical Cardiac Electrophysiology · Ann Arbor, MINPI 1912020553

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,625 of the $46,659 with a category attached, or 76.4%. 7 manufacturers reported payments, led by Boston Scientific at 47.6% of the total.

$46,659in general payments, 2019–2025

Across 59 payments — averaging $790.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$22K
  • Preventice Services, LLC$13K
  • Abbott$5K
  • Medtronic$5K
  • Impulse Dynamics (USA) Inc.$1K
  • Irhythm Technologies, Inc.$265
  • plus $177 from 1 others
$61,457in research payments, 2019–2025

Across 111 payments — averaging $553.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$32K
  • Biotronik Inc.$28K
  • Medtronic$2K

What the payments were for

  • Consulting fees$35,62576%
  • Speaking & faculty fees$4,2009%
  • Travel & lodging$4,63310%
  • Food & beverage$2,2015%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,659 in reported general payments places this provider in the 70th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

See all clinical cardiac electrophysiology providers in Michigan

Medicare billing

Part B allowed, 2024
$26,399
Medicare patients
201
Services billed
282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban65$87,480
XareltoRivaroxaban25$35,597
Dofetilide28$5,937
Mexiletine Hcl15$3,263
Metoprolol Succinate28$697
Amiodarone Hcl30$666
SotalolSotalol Hcl12$262
Metoprolol Tartrate15$134

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →